MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 187 filers reported holding MEDICINES CO in Q1 2015. The put-call ratio across all filers is 1.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $895,000 | +40.3% | 18,300 | -2.7% | 0.00% | 0.0% |
Q4 2016 | $638,000 | -2.9% | 18,800 | +8.0% | 0.00% | 0.0% |
Q3 2016 | $657,000 | +43.8% | 17,400 | +27.9% | 0.00% | 0.0% |
Q2 2016 | $457,000 | -4.8% | 13,600 | -9.9% | 0.00% | 0.0% |
Q1 2016 | $480,000 | -17.7% | 15,100 | -3.2% | 0.00% | 0.0% |
Q4 2015 | $583,000 | +10.4% | 15,600 | +12.2% | 0.00% | 0.0% |
Q3 2015 | $528,000 | -78.8% | 13,900 | -84.0% | 0.00% | -75.0% |
Q2 2015 | $2,489,000 | -0.1% | 87,000 | -2.1% | 0.00% | 0.0% |
Q1 2015 | $2,491,000 | +10.9% | 88,900 | +9.5% | 0.00% | 0.0% |
Q4 2014 | $2,247,000 | +30.6% | 81,200 | +5.3% | 0.00% | +33.3% |
Q3 2014 | $1,721,000 | -23.9% | 77,100 | -0.9% | 0.00% | -25.0% |
Q2 2014 | $2,261,000 | -48.6% | 77,800 | -49.7% | 0.00% | -50.0% |
Q1 2014 | $4,399,000 | -20.2% | 154,800 | +8.5% | 0.01% | -20.0% |
Q4 2013 | $5,511,000 | +19.8% | 142,700 | +3.9% | 0.01% | +11.1% |
Q3 2013 | $4,602,000 | +22.7% | 137,300 | +12.6% | 0.01% | +12.5% |
Q2 2013 | $3,750,000 | – | 121,900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 4,202,000 | $153,246,000 | 19.10% |
Antipodean Advisors LLC | 257,000 | $9,373,000 | 11.40% |
Aviva Holdings Ltd. | 982,831 | $35,844,000 | 7.50% |
BRIDGER MANAGEMENT, LLC | 2,314,014 | $84,392,000 | 6.62% |
Slate Path Capital LP | 3,545,000 | $129,286,000 | 5.80% |
CVI Holdings, LLC | 338,850 | $12,357,000 | 4.78% |
DLD Asset Management, LP | 2,917,800 | $106,412,000 | 4.43% |
Camber Capital Management LP | 1,700,000 | $61,999,000 | 2.89% |
Maven Securities LTD | 109,386 | $3,994,000 | 2.66% |
Parian Global Management LP | 110,100 | $4,015,000 | 2.60% |